Susan Branscombe Coyle

Senior Manager, Marketing at La Jolla Pharmaceutical

Susan Branscombe Coyle has a diverse work experience spanning several industries and roles. Susan most recently worked as a Senior Manager of Marketing at Innoviva Specialty Therapeutics, Inc. starting in February 2023. Before that, from March 2020 to February 2023, they held the position of Senior Manager of Marketing at Fresenius Medical Care North America. In this role, they partnered with product managers and subject matter experts on marketing efforts, managed a team of marketing and project managers, and acted as a mentor to their team. Susan's previous experience includes working as a Senior Account Manager at Davis Advertising from January 2015 to March 2020, leading the development of integrated marketing plans and managing cross-functional teams. Susan also served as a Senior Account Executive at Cambridge BioMarketing in a contract position in 2014, leading a marketing team for a major drug launch. Prior to that, they worked as a Sales Director of Advertising and Marketing Programs at Health Monitor Network from 2008 to 2013, developing customized marketing proposals and coordinating with internal production teams. Susan also has experience as a Marketing Manager at EH Publishing from 2006 to 2008, managing email campaigns and creating marketing pieces for industry events. Susan began their career as a Marketing Manager of Partner Programs at PTC from 1999 to 2003, where they created and launched print communications and directed integrated marketing campaigns.

Susan Branscombe Coyle attended the University of Massachusetts Amherst. However, no information is available regarding the specific degree, field of study, start year, or end year of their education at the university.

Location

Boston, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


La Jolla Pharmaceutical

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.


Industries

Employees

51-200

Links